|
Michael Sharpe (psychiatrist)Michael Sharpe is a British psychiatrist and academic, specialising in the psychiatric aspects of medical illness. He is an Emeritus Professor of Psychological Medicine at the University of Oxford and a Fellow of Saint Cross College, Oxford. From 1997 to 2011, he was Professor of Psychological Medicine at the University of Edinburgh.[1][2] Sharpe was the elected President of the European Association of Psychosomatic Medicine for 2022-2023.[3] WorkWhile a Professor at Oxford, Sharpe ran a research programme to develop and evaluate psychiatric treatments for medically ill patients.[4] Sharpe is best known as a co-author on the controversial PACE trial which found exercise and cognitive behavioural therapy to be “moderately effective” treatments for Myalgic Encephalomyelitis.[5] In 2021 he controversially gave a presentation on secondary covid 19 impacts[6] to Swiss Re in which he suggested that Long COVID was partly caused by psychological and social factors such as reportage by the Guardian columnist George Monbiot.[7] Sharpe's recent work is on depression in people with cancer and the mental health of elderly inpatients.[8] HonoursIn 2009, he was named Psychiatric Academic of the Year by the Royal College of Psychiatrists.[9] In 2014, he was named Psychiatrist of the Year by the Royal College of Psychiatrists.[10] References
|
||||||||
Portal di Ensiklopedia Dunia
